Get startedLog in
    Picture of Radiopharm Theranostics logo

    RAD — Radiopharm Theranostics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Rad Receives Approval For Phase 1 Therapeutic Study Of Pdl1-Nanobody In Non-Small Cell Lung Cancer

    Picture of Radiopharm Theranostics logoRadiopharm Theranostics
    09/10/2023 13:30
    Oct 9 (Reuters) - Radiopharm Theranostics Ltd  RAD.AX :
    * RAD RECEIVES APPROVAL FOR PHASE 1 THERAPEUTIC STUDY OF
PDL1-NANOBODY IN NON-SMALL CELL LUNG CANCER
    * RADIOPHARM THERANOSTICS LTD - TRIAL IS EXPECTED TO START
SHORTLY

Source text for Eikon:  ID:nGNX8Hpqry 
Further company coverage:  RAD.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Radiopharm Theranostics

    See all news